A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral Sclerosis

Johns Hopkins ALS Clinical Trials Unit, Baltimore

Mayo Clinic, Jacksonville

Mayo Clinic, Rochester

Cedars-Sinai Medical Center, Los Angeles

UC Irvine Health ALS and Neuromuscular Center, Irvine

Forbes Norris MDA/ALS Research and Treatment Center, San Francisco

Healey & AMG Center for ALS Research, Boston

University of Calgary - Heritage Medical Research Clinic, Calgary

University of Alberta, Edmonton

Stan Cassidy Centre for Rehabilitation, Fredericton

London Health Sciences Centre, London

Sunnybrook Research Institute, Toronto

Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal

Montreal Neurological Institute and Hospital, Montreal